Trial intelligence / Profile preview

Efficacy of Topiramate in the treatment of Schizophrenia

IRCT201303287373N3Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of topiramate in schizophrenia, sponsored by Arak University of Medical Sciences. Started Mar 2013; status: completed.

02

Drugs

topiramate
03

Conditions

schizophrenia

Beyond the preview

Go deeper on IRCT201303287373N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201303287373N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call